HeimFRE • FRA
add
Fresenius
Við síðustu lokun
33,46 €
Dagbil
33,36 € - 33,56 €
Árabil
24,06 € - 35,00 €
Markaðsvirði
18,98 ma. EUR
Meðalmagn
2,19 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
ETR
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (EUR) | jún. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 5,46 ma. | 4,10% |
Rekstrarkostnaður | 958,00 m. | 4,47% |
Nettótekjur | -373,00 m. | -566,25% |
Hagnaðarhlutfall | -6,83 | -546,41% |
Hagnaður á hvern hlut | 0,81 | 20,90% |
EBITDA | 567,00 m. | 38,29% |
Virkt skatthlutfall | 107,59% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (EUR) | jún. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 1,11 ma. | -55,16% |
Heildareignir | 43,51 ma. | -43,06% |
Heildarskuldir | 23,91 ma. | -46,85% |
Eigið fé alls | 19,60 ma. | — |
Útistandandi hlutabréf | 563,24 m. | — |
Eiginfjárgengi | 0,99 | — |
Arðsemi eigna | 1,51% | — |
Ávöxtun eigin fjár | 1,96% | — |
Peningaflæði
Breyting á handbæru fé
| (EUR) | jún. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | -373,00 m. | -566,25% |
Handbært fé frá rekstri | — | — |
Reiðufé frá fjárfestingum | — | — |
Reiðufé frá fjármögnun | — | — |
Breyting á handbæru fé | — | — |
Frjálst peningaflæði | — | — |
Um
Fresenius SE & Co. KGaA is a European multinational health care company based in Bad Homburg vor der Höhe, Germany. It provides products and services for dialysis in hospitals, as well as inpatient and outpatient medical care. The company is involved in hospital management and in engineering and services for medical centers and other health care facilities.
The company is ranked 411th in the Forbes Global 2000 list in 2023.
In March 2022, it announced plans to merge with InterWell Health and Cricket Health to form a new company, which will operate under the InterWell Health brand, focused on services for the earlier stages of kidney disease. Wikipedia
Framkvæmdastjóri
Stofnsett
1912
Höfuðstöðvar
Vefsvæði
Starfsfólk
175.771
